Table 2 Clinical characteristics and mean quality of life scores in diabetic retinopathy patients with different clinical profile
Clinical factors | Number of patients n(%) | Mean EQ-5D-5Â L score (SD) | Mean NEI-VFQ-25 composite score (SD) | Mean EQ-VAS score (SD) |
|---|---|---|---|---|
Type of diabetes | Â | Â | Â | Â |
Type I | 12 (4%) | 0.70 (0.32) | 57.71 (29.9) | 62.92 (20.05) |
Type II | 288 (96%) | 0.70 (0.33) | 61.22 (31.02) | 67.76 (16.72) |
Duration of diabetes | Â | Â | Â | Â |
≤ 10 years | 146 (48.67%) | 0.71 (0.33) | 60.28 (30.45) | 69.01 (16.26) |
11–15 years | 53 (17.67%) | 0.75 (0.3) | 69.05 (31.1) | 71.32 (16.03) |
> 15 years | 101 (33.67%) | 0.66 (0.35) | 58.06 (31.14) | 63.51 (17.49) |
Glycaemic control | Â | Â | Â | Â |
Controlled | 239 (80.47%) | 0.71 (0.33) | 62.78 (30.97) | 68.47 (16.3) |
Uncontrolled | 58 (19.53%) | 0.64 (0.36) | 53.69 (30.71) | 63.88 (18.78) |
Duration of DR | Â | Â | Â | Â |
1–6 months | 220 (73.33%) | 0.69 (0.33) | 61.23 (30.67) | 67.27 (16.39) |
7–12 months | 50 (16.67%) | 0.73 (0.3) | 62.26 (30.88) | 68.8 (18) |
> 12 months | 30 (10%) | 0.66 (0.42) | 58.06 (33.72) | 67.67 (18.74) |
Stage of DR (Worse eye) | Â | Â | Â | Â |
NPDR | 31 (10.33%) | 0.82 (0.21) | 66.67 (29.22) | 74.35 (14.82) |
PDR | 133 (44.33%) | 0.72 (0.33) | 63.52 (30.32) | 68.16 (16.63) |
NPDR + ME | 29 (9.67%) | 0.72 (0.2) | 58.61 (30.77) | 68.62 (15.17) |
PDR + ME | 107 (35.67%) | 0.62 (0.37) | 57.09 (32.06) | 64.58 (17.63) |
Number of affected eyes | Â | Â | Â | Â |
1 | 16 (5.3%) | 0.68 (0.35) | 60.52 (32.11) | 68.13 (17.21) |
2 | 284 (94.7%) | 0.70 (0.33) | 61.11 (30.92) | 67.54 (16.87) |
Visual acuity (Better eye) | Â | Â | Â | Â |
Normal | 77 (25.67%) | 0.92 (0.11) | 89.02 (9.65) | 80.32 (8.36) |
Mild | 61 (20.33%) | 0.85 (0.14) | 82.52 (16.89) | 76.31 (10.32) |
Moderate | 85 (28.33%) | 0.72 (0.24) | 56.31 (20.66) | 66.88 (12.58) |
Severe | 33 (11%) | 0.42 (0.43) | 28.52 (14.17) | 54.09 (11.56) |
Blind | 44 (14.67%) | 0.27 (0.31) | 16.1 (11.36) | 44.55 (14.58) |
Treatment status | Â | Â | Â | Â |
Laser | 190 (63.3%) | 0.68 (0.34) | 58.94 (31.54) | 66.76 (16.79) |
Intravitreal injections and laser | 72 (24%) | 0.71 (0.34) | 63.38 (31.01) | 66.94 (17.49) |
Others | 12 (4%) | 0.70 (0.44) | 71.29 (20.8) | 78.33 (15.86) |
Not on treatment | 26 (8.7%) | 0.77 (0.17) | 65.64 (29.68) | 70.19 (14.8) |
Co-morbidities | Â | Â | Â | Â |
Yes | 41 (13.67%) | 0.61 (0.41) | 61.6 (29.29) | 67.8 (17.1) |
No | 259 (86.33%) | 0.71 (0.32) | 61 (31.24) | 67.53 (16.85) |